Skip to main content Accessibility help
×
Home

Anticlotting drugs and regional anaesthetic and analgesic techniques: comparative update of the safety recommendations

  • J. V. Llau (a1), J. De Andrés (a2), C. Gomar (a3), A. Gómez-Luque (a4), F. Hidalgo (a5) and L. M. Torres (a6)...

Summary

The wide use of anticlotting drugs by patients scheduled for surgery is a challenge for the anaesthesiologist when considering a regional anaesthesia technique. This practice seems safe if there is an appropriate management based on safety intervals established according to the pharmacology of the drug and the regional technique. Some anaesthesiology societies have published recommendations for the safe practice of regional anaesthesia with the simultaneous use of anticoagulants (heparin, low molecular weight heparins, oral anticoagulants (OA), fondaparinux and others) and antiplatelet agents (aspirin, clopidogrel, ticlopidine, argatroban and others). One of the most recent guidelines has been published by the Spanish Society of Anaesthesia and Critical Care. This article reviews these recommendations and compares them with others published in the last years. The recommendations are similar, but some interesting differences can be observed and need to be considered. A European consensus in this setting would probably be necessary.

Copyright

Corresponding author

Correspondence to: Juan V. Llau, Department of Anaesthesiology, Critical Care and Pain Therapy, Hospital Clínico Universitario, Avda. Blasco Ibáñez, 17, 46010, Valencia, Spain. E-mail: juanvllau@terra.es; Tel: +34 963862653; Fax: +34 963862644

References

Hide All
1.Horlocker, TT, Wedel, DJ, Schoroder, SH, Elliot, BA, McGregor, DG, Wong, GY. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anest Analg 1995; 80: 303309.
2.Horlocker, TT, Wedel, DJ, Benzon, H et al. . Regional anesthesia in the anticoagulated patient: Defining the risks. Reg Anesth Pain Med 2004; 29 (Suppl 1): 111.
3.Llau, JV, De Andrés, J, Gomar, C et al. . Drugs that alter hemostasis and regional anesthetic techniques: safety guidelines. Consensus conference (Spanish). Rev Esp Anestesiol Reanim 2001; 48: 270278.
4.Gogarten, W, Van Aken, H, Büttner, J, Riess, H, Wulf, H, Buerkle, H. Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe / antithrombotische Medikation. Überarbeitete Leitlinien der Deustchen Gesellschaft für Anästhesiologie und Intensivmedizin. Anästh Intensivmed 2003; 44: 218230.
5.Horlocker, TT, Wedel, DJ, Benzon, H et al. . Regional anesthesia in the anticoagulated patient: Defining the risks (The Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28: 172197.
6.Llau Pitarch, JV, De Andrés Ibáñez, J, Gomar Sancho, C, Gómez Luque, A, Hidalgo Martínez, F, Torres Morera, LM. Guidelines of hemostasis inhibiting drugs and neuraxial anaesthesia (Spanish). Rev Esp Anestesiol Reanim 2005; 52: 413420.
7.Kozek-Langenecker, SA, Fries, D, Gütl, M et al. . Lokoregionalanästhesien unter gerinnungshemmender Medikation. Anaesthesist 2005; 54: 476484.
8.Vandermeulen, E, Singelyn, F, Vercauteren, M, Brichant, JF, Ickx, BE, Gautier, P. Belgian guidelines concerning central neural blockade in patients with drug induced alteration of coagulation: an update. Acta Anaesthesiol Belg 2005; 56: 139146.
9.Samama, CM, Bastien, O, Forestier, F et al. , and the expert group. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 – Summary statement. Can J Anesth 2002; 49: S26S35.
10.Llau Pitarch, JV, De Andrés Ibáñez, J, Gomar Sancho, C, Gómez Luque, A, Hidalgo Martínez, F, Torres Morera, LM. Hemostasis-altering drugs and techniques for regional anaesthesia and analgesia: safety recommendations (Spanish). Rev Esp Anestesiol Reanim 2005; 52: 248250.
11.Llau Pitarch, JV, De Andrés Ibáñez, J, Gomar Sancho, C, Gómez Luque, A, Hidalgo Martínez, F, Torres Morera, LM. Hemostasis-altering drugs and regional anaesthetic techniques: safety guidelines (Spanish). Rev Esp Anaestesiol Reanim 2004; 51: 137142.
12.Llau Pitarch, JV, De Andrés Ibáñez, J, Gomar Sancho, C, Gómez Luque, A, Hidalgo Martínez, F, Torres Morera, LM. European Society for Regional Anaesthesia: Locoregional anaesthesia and drugs that affect hemostasis. Suggestions of the expert meeting in the ESRA Congress in Barcelona. Rev Esp Anestesiol Reanim 2002; 49: 468473.
13.Geerts, WH, Heit, JA, Clagett, GP et al. . Prevention of venous thromboembolism. Chest 2001; 119 (Suppl): 132S175S.
14.Turpie, AG. State of the art – a journey through the world of antithrombotic therapy. Semin Thromb Hemost 2002; 28 (Suppl 3): 311.
15.Horlocker, TT, Wedel, DJ. Neuraxial block and low-moleular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med 1998; 23 (Suppl 2): 164177.
16.Tryba, M. European practice guidelines: thromboembolism prophylaxis and regional anesthesia. Reg Anesth Pain Med 1998; 23 (Suppl 2): 178182.
17.Lee, BB. Neuraxial complications after epidural and spinal anaesthesia. Acta Anaesthesiol Scand 2003; 47: 371373.
18.Tyagi, A, Bhattacharya, A. Central neuraxial blocks and anticoagulation: a review of current trends. Eur J Anaesthesiol 2002; 19 (5): 317329.
19.Franchini, M. The platelet function analyzer (PFA-100): an update on its clinical use. Clin Lab 2005; 51: 367372.
20.Mandal, NJ. PFA-100 and regional anesthesia. Br J Anaesth 2004; 93: 468.
21.Favaloro, EJ. Clinical application of the PFA-100. Curr Opin Hematol 2002; 9: 407415.
22.Tyagi, A, Bhattacharya, A. Central neuraxial blocks and anticoagulation: a review of current trends. Eur J Anaesthesiol 2002; 19: 317329.
23.Mentegazzi, F, Danelli, G, Ghisi, D, Tosi, M, Gennari, A, Fanelli, G. Locoregional anesthesia and coagulation. Minerva Anestesiol 2005; 71: 497499.
24.Geerts, WH, Pineo, GF, Heit, JA et al. . Prevention of venous thromboembolism. Chest 2004; 126: 338S400S.
25.Weitz, JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688698.
26.Hirsh, J, Warkentin, TE, Shaughenessy, SG et al. . Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119 (Suppl): 64S94S.
27.White, RH, Ginsberg, JS. Low-molecular-weight heparins: are they all the same? Br J Haematology 2003; 121: 1220.
28.Strebel, N, Prins, N, Agnelli, G, Buller, HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002; 162: 14511456.
29.Llau Pitarch, JV, Ferrandis Comes, R, García-Pérez, ML. Regional anaesthesia, thromboprophylaxis and their relationship with the spinal hematoma: Spanish experience (Spanish). Med Clin (Barc) 2003; 121: 414417.
30.Tufano, A, Cerbone, AM, Di Minno, G. The use of antithrombotic drugs in older people. Minerva Med 2002; 93: 1326.
31.Patrono, C, Coller, B, FitzGerald, GA, Hirsh, J, Roth, G. Platelet active drugs: the relationships among dose, effectiveness, and side effects. Chest 2004; 126: 234S264S.
32.CLASP (Collaborative Low-Dose Aspirin Study in Pregnancy): a randomized trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619629.
33.Pulmonary Embolism Prevention (PEP) Trial Collaborative Group: prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP). Lancet 2000; 355: 12951302.
34.Kövesi, T, Royston, D. Is there a bleeding problem with platelet-active drugs? (Editorial). BJA 2002; 88: 159162.
35.Burger, W, Chemnitus, JM, Kneissl, GD, Rücher, G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation- review. J Inter Med 2005; 257: 399414.
36.Tam, NL, Pac-Soo, C, Pretorius, PM. Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br J Anaesth 2006; 96: 262265.
37.Litz, RJ, Gottschlich, B, Stehr, SN. Spinal epidural hematoma after spinal anesthesia in a patient treated with clopidogrel and enoxaparin. Anesthesiology 2004; 101: 14671470.
38.Ansell, J, Hirsh, J, Poller, L, Bussey, H, Jacobson, A, Hylek, E. The pharmacology and management of the vitamin k antagonists. Chest 2004; 126: 204S233S.
39.Dunn, A, Turpie, AGG. Perioperative management of patients on oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901908.
40.Hirsh, J, Raschke, R. Heparin and low molecular-weight heparin. Chest 2004; 126: 188S203S.
[41]Cantó, M. Regional anaesthesia in cardiac surgery. Future or reality? (Ed) (Spanish). Rev Esp Anestesiol Reanim 2003; 50: 319325.
42.Weitz, JI, Hirsh, J, Samama, MM. New anticoagulant drugs. Chest 2004; 126: 265S286S.
43.Donat, F, Duret, JP, Santoni, A et al. . The pharmacokinetics of fondaparinux sodium in healthy volunteers. Clin Pharmacokinet 2002; 41 (Suppl 2): 19.
44.Bauer, KA, Hawkins, DW, Peters, PC et al. . Fondaparinux, a syntetic pentasaccharide: the first of a new class of antithrombotic agents – the selective factor Xa inhibitors. Cardiovasc Drug Rev 2002; 20: 3752.
45.Keam, SJ, Goa, KL. Fondaparinux sodium. Drugs 2002; 62: 16731685.
46.Westphal, M, Booke, M. Zum neuartigen Antithrombotikum Fondaparinux. Anästh Intensivmed 2003; 44: 324325.
47. Singelyn FJ, Felicissimo P, Piovella F et al. Extended thromboprophylaxis with fondaparinux (Arixtra) after major orthopedic lower limb surgery: the EXPERT study. Oral Presentation, Lisbon EFORT, 2005, June 4–7 2005.

Keywords

Anticlotting drugs and regional anaesthetic and analgesic techniques: comparative update of the safety recommendations

  • J. V. Llau (a1), J. De Andrés (a2), C. Gomar (a3), A. Gómez-Luque (a4), F. Hidalgo (a5) and L. M. Torres (a6)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed